These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7328844)

  • 1. [A comparative study of serum bile acid levels (TBA, CG) in liver disease-difference between fasting and UDCA oral loading (author's transl)].
    Hino K; Yamamoto S; Yamashita S; Fukushima K; Ohashi K
    Nihon Shokakibyo Gakkai Zasshi; 1981 Nov; 78(11):2197. PubMed ID: 7328844
    [No Abstract]   [Full Text] [Related]  

  • 2. [Change of serum bile acids levels after administration of UDCA and test meals (author's transl)].
    Inaguma H
    Nihon Shokakibyo Gakkai Zasshi; 1982 Feb; 79(2):289. PubMed ID: 7098117
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance and limitations of oral UDCA loading in liver function test].
    Matsuzaki Y; Osuga T; Shoda J; Imawari M; Mitamura K
    Nihon Rinsho; 1984 Jul; 42(7):1671-6. PubMed ID: 6492410
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnostic value of oral bile acid tolerance test (author's transl)].
    Matsumoto H; Masamune O; Nunode Y; Ohshiba S
    Nihon Shokakibyo Gakkai Zasshi; 1981 Jul; 78(7):1380-7. PubMed ID: 7311082
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease.
    Colombo C; Crosignani A; Alicandro G; Zhang W; Biffi A; Motta V; Corti F; Setchell KDR
    J Pediatr; 2016 Oct; 177():59-65.e1. PubMed ID: 27297203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of ursodeoxycholic acid on the biliary lipids secretion (author's transl)].
    Yanaura S; Izuka A; Ishikawa S
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):261-7. PubMed ID: 7327454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
    Chretien Y; Poupon R; Gherardt MF; Chazouilleres O; Labbe D; Myara A; Trivin F
    Gut; 1989 Aug; 30(8):1110-5. PubMed ID: 2767508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of ursodeoxycholic acid. Glucagon tolerance test in patients with chronic liver disease].
    Yamashita Y; Moriyasu F; Kimura T; Ono S; Kawasaki T; Tamada T; Ban N; Nakamura T; Uchino H
    Nihon Shokakibyo Gakkai Zasshi; 1988 Dec; 85(12):2651-7. PubMed ID: 3244182
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral ursodeoxycholic acid tolerance test in patients with digestive disease.
    Yamanishi Y; Kishimoto Y; Kawasaki H; Hirayama C; Ikawa S
    Gastroenterol Jpn; 1981; 16(5):472-7. PubMed ID: 7327385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormality of oral ursodeoxycholic acid tolerance test in the Dubin-Johnson syndrome.
    Kawasaki H; Yamanishi Y; Kishimoto Y; Hirayama C; Ikawa S; Kuchiba K; Kondo T
    Clin Chim Acta; 1981 Apr; 112(1):13-9. PubMed ID: 7237821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of bile acid tolerance tests in patients with liver diseases (author's transl)].
    Morita T; Matsuyama Y; Higuchi M
    Rinsho Byori; 1981 May; 29(5):467-70. PubMed ID: 7289111
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical significance of the determination of serum bile acid and oral bile acid loading test in gastrointestinal diseases].
    Matsuzaki Y; Osuga T; Imawari M; Shoda J; Mitamura K; Kozawa K
    Nihon Shokakibyo Gakkai Zasshi; 1985 May; 82(5):1369-79. PubMed ID: 4032834
    [No Abstract]   [Full Text] [Related]  

  • 13. [The oral ursodeoxycholic acid test and its value in the diagnosis of liver diseases].
    Goszcz A
    Pol Tyg Lek; 1986 Apr; 41(17):547-51. PubMed ID: 3737462
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.
    Colombo C; Setchell KD; Podda M; Crosignani A; Roda A; Curcio L; Ronchi M; Giunta A
    J Pediatr; 1990 Sep; 117(3):482-9. PubMed ID: 2391610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fasting and post-prandial serum bile acids as liver function tests in chronic liver diseases (author's transl)].
    Poupon RY; Poupon RE; Erlinger S; Darnis F
    Gastroenterol Clin Biol; 1978 Nov; 2(11):873-6. PubMed ID: 748077
    [No Abstract]   [Full Text] [Related]  

  • 17. 125I Radioimmunoassay of serum ursodeoxycholyl conjugates.
    Hill A; Ross PE; Bouchier IA
    Clin Chim Acta; 1983 Feb; 127(3):327-36. PubMed ID: 6839487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ursodeoxycholic acid on cholesterol gallstone dissolution (author's transl)].
    Nambu M; Kuroda H; Namihisa T; Ohama H; Maeda M
    Nihon Shokakibyo Gakkai Zasshi; 1978 Nov; 75(11):1768-80. PubMed ID: 731984
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical usefulness of serum cholylglycine determination in various liver diseases.
    Tanggo Y; Fujiyama S; Kin F; Tashiro A; Shiraoku H; Akahoshi M; Sato Y; Hashiguchi O; Sagara K
    Gastroenterol Jpn; 1982 Oct; 17(5):447-52. PubMed ID: 7173571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 6-8 weeks of oral ursodeoxycholic acid administration on serum concentrations of fasting and postprandial bile acids and biochemical analytes in healthy dogs.
    Deitz KL; Makielski KM; Williams JM; Lin H; Morrison JA
    Vet Clin Pathol; 2015 Sep; 44(3):431-6. PubMed ID: 26274488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.